Authors

• Masey Ross
• Amber Hendrix
• Daniel Flora (ORCID: https://orcid.org/0000-0002-0762-5041)
• Mary Helen Hackney (ORCID: https://orcid.org/0000-0002-3460-9573)
• Michael O. Idowu (ORCID: https://orcid.org/0000-0002-7416-5444)
• Kandace P. McGuire (ORCID: https://orcid.org/0000-0001-9810-0007)
• Dipankar Bandyopadhyay (ORCID: https://orcid.org/0000-0001-5421-1725)
• Daniel G. Stover (ORCID: https://orcid.org/0000-0001-9003-8165)
• Tasnim Rahman (ORCID: https://orcid.org/0009-0006-8184-1128)
• Amelia Grover (ORCID: https://orcid.org/0000-0002-2755-5538)
• Raphael J. Louie (ORCID: https://orcid.org/0000-0003-2429-4499)
• Harry D. Bear (ORCID: https://orcid.org/0000-0002-7632-9019)
• Patrick M. Dillon (ORCID: https://orcid.org/0000-0003-0622-725X)
• Hetal Vachhani
• Maciej Kmieciak (ORCID: https://orcid.org/0000-0002-0889-5529)
• Taylor M. Jenkins (ORCID: https://orcid.org/0000-0001-5776-2370)
• Andrew Poklepovic (ORCID: https://orcid.org/0000-0002-4015-5037)
• Xiaoyan Deng
• Lindsey Gwaltney
• Monique Williams
• Giovanni Archer

Institutions

• Virginia Commonwealth University (US)
• St. Elizabeth Healthcare (US)
• Dana-Farber Cancer Institute (US)
• University of Virginia Cancer Center
• University of Virginia (US)
• The Ohio State University (US)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2025-02-01

DOI

https://doi.org/10.1136/jitc-2024-010294

Citations

12

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

12.54

Funders

• Commonwealth Foundation for Cancer Research Foundation
• National Institutes of Health
• National Cancer Institute